Assessment of an oral oncology drug repository program and strategies for expansion into nononcology medications
The strategic expansion of OSUWMC's drug repository program, characterized by incremental program expansion, stakeholder engagement, operational optimization, and continuous education, serves as a valuable framework for institutions seeking to broaden their repository efforts. As healthcare organizations explore innovative solutions for improving medication access, the experiences shared in this report provide practical insights that can guide the development and expansion of drug repository programs nationwide.
Authors
- Julie Kennerly-Shah (ORCID: https://orcid.org/0000-0003-2329-434X)
- A. Triglia
- Jennifer P Booth (ORCID: https://orcid.org/0000-0003-4214-147X)
- Marjorie V. Neidecker (ORCID: https://orcid.org/0000-0001-9566-4683)
- Kevin Wolowiec
Institutions
- The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (US)
- The Ohio State University Wexner Medical Center (US)
- MNM Consulting (France) (FR)
- The Ohio State University (US)
Publication Details
- Journal
- American Journal of Health-System Pharmacy
- Published
- 2025-06-27
- DOI
- https://doi.org/10.1093/ajhp/zxaf085
- Primary Topic
- Pharmaceutical Practices and Patient Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00